Загрузка...
De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early?
Dual antiplatelet treatment (DAPT) is the treatment of choice to prevent atherothrombotic events in patients with acute coronary syndrome (ACS) treated with percutaneous interventions (PCIs). The availability of different P2Y12 inhibitors set the stage for costum made DAPT, as to achieve the highest...
Сохранить в:
| Опубликовано в: : | Eur Heart J Suppl |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7270966/ https://ncbi.nlm.nih.gov/pubmed/32523457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa078 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|